Literature DB >> 18638083

Practical guidance for dialyzing a hemodialysis patient following acute brain injury.

Andrew Davenport1.   

Abstract

The incidence of acute brain injury in chronic hemodialysis patients is increasing, as the dialysis population is becoming increasingly older, often hypertensive, at risk of ischemic and/or hemorrhagic stroke, and subdural hemorrhage. Standard intermittent hemodialysis treatments typically lead to an increase in cerebral swelling, which can exacerbate underlying cerebral damage. In critically ill patients, continuous modes of renal replacement therapy may be required, but depending upon the clinical condition, simple modifications to standard intermittent therapies may suffice, and allow effective delivery of renal replacement therapy, but ensure that patient outcomes both in terms of mortality and residual functional brain damage is no different between those with normal renal function and those on the chronic dialysis program.

Entities:  

Mesh:

Year:  2008        PMID: 18638083     DOI: 10.1111/j.1542-4758.2008.00271.x

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  11 in total

Review 1.  Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant.

Authors:  Michael Ganetsky; Kavita M Babu; Steven D Salhanick; Robert S Brown; Edward W Boyer
Journal:  J Med Toxicol       Date:  2011-12

2.  Association between intravenous contrast media exposure and non-recovery from dialysis-requiring septic acute kidney injury: a nationwide observational study.

Authors:  Yoshihisa Miyamoto; Masao Iwagami; Shotaro Aso; Hideo Yasunaga; Hiroki Matsui; Kiyohide Fushimi; Yoshifumi Hamasaki; Masaomi Nangaku; Kent Doi
Journal:  Intensive Care Med       Date:  2019-08-26       Impact factor: 17.440

Review 3.  Dialysis-induced worsening of cerebral edema in intracranial hemorrhage: a case series and clinical perspective.

Authors:  Abhay Kumar; Andreia Cage; Rajat Dhar
Journal:  Neurocrit Care       Date:  2015-04       Impact factor: 3.210

4.  Rapid unexpected brain herniation in association with renal replacement therapy in acute brain injury: caution in the neurocritical care unit.

Authors:  Marcey Osgood; Rebecca Compton; Raphael Carandang; Wiley Hall; Glenn Kershaw; Susanne Muehlschlegel
Journal:  Neurocrit Care       Date:  2015-04       Impact factor: 3.210

5.  Osmotic Shifts, Cerebral Edema, and Neurologic Deterioration in Severe Hepatic Encephalopathy.

Authors:  Eric Michael Liotta; Anna L Romanova; Bryan D Lizza; Laura J Rasmussen-Torvik; Minjee Kim; Brandon Francis; Rajbeer Singh Sangha; Timothy J Carroll; Daniel Ganger; Daniela P Ladner; Andrew M Naidech; James J Paparello; Shyam Prabhakaran; Farzaneh A Sorond; Matthew B Maas
Journal:  Crit Care Med       Date:  2018-02       Impact factor: 7.598

Review 6.  Clinical review: use of renal replacement therapies in special groups of ICU patients.

Authors:  Eric A J Hoste; Annemieke Dhondt
Journal:  Crit Care       Date:  2012-01-19       Impact factor: 9.097

7.  Course of encephalopathy in a cirrhotic dialysis patient treated sequentially with peritoneal and hemodialysis.

Authors:  Suleyman Koz; Idris Sahin; Zafer Terzi; Sema Tulay Koz
Journal:  Case Rep Med       Date:  2015-03-25

8.  Spontaneous nontraumatic subarachnoid hemorrhage without cerebrovascular malformations in a maintenance hemodialysis patient.

Authors:  R Jayasurya; N Murugesan; R Kumar; A K Dubey; P S Priyamvada; R P Swaminathan; S Parameswaran
Journal:  Indian J Nephrol       Date:  2015 Sep-Oct

9.  Increased Intracranial Pressure during Hemodialysis in a Patient with Anoxic Brain Injury.

Authors:  Anton Lund; Mette B Damholt; Ditte G Strange; Jesper Kelsen; Hasse Møller-Sørensen; Kirsten Møller
Journal:  Case Rep Crit Care       Date:  2017-03-20

10.  Influence of chronic kidney disease and haemodialysis on stroke outcome.

Authors:  Shrikant D Pande; Julie Morris
Journal:  Singapore Med J       Date:  2020-04-03       Impact factor: 1.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.